Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A neuroendocrine view of ECT.

S J Cooper1, A I Scott, L J Whalley

  • 1Department of Mental Health, Queen's University of Belfast.

The British Journal of Psychiatry : the Journal of Mental Science
|November 1, 1990
PubMed
Summary

Convulsive therapy may work by correcting hypothalamic dysfunction, a potential cause of mood disorders. Seizures appear to boost a peptide called antidepressin, which resolves neuroendocrine and behavioral issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intellectual engagement and cognitive ability in later life (the "use it or lose it" conjecture): longitudinal, prospective study.

BMJ (Clinical research ed.)·2018
Same author

The influence of childhood intelligence, social class, education and social mobility on memory and memory decline in late life.

Age and ageing·2018
Same author

Examining non-syndromic autosomal recessive intellectual disability (NS-ARID) genes for an enriched association with intelligence differences.

Intelligence·2016
Same author

Life course socioeconomic status and the decline in information processing speed in late life.

Social science & medicine (1982)·2016
Same author

Can we reduce the risk of dementia?

QJM : monthly journal of the Association of Physicians·2014
Same author

Human cognitive ability is influenced by genetic variation in components of postsynaptic signalling complexes assembled by NMDA receptors and MAGUK proteins.

Translational psychiatry·2014

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Metabolic research

Background:

  • Affective disorders are hypothesized to stem from hypothalamic dysfunction and a deficiency in a critical mood-regulating peptide.
  • The diabetes/insulin model provides a framework for understanding these neuroendocrine imbalances.

Purpose of the Study:

  • To propose a neuroendocrine hypothesis for the clinical efficacy of convulsive therapy.
  • To elucidate the role of a specific hypothalamic peptide in mood regulation and treatment response.

Main Methods:

  • Description of a neuroendocrine hypothesis linking hypothalamic function to affective disorders.
  • Exploration of the proposed mechanism of action for convulsive therapy via peptide release.

Main Results:

  • Convulsive therapy, through induced seizures, is suggested to enhance the production and release of the hypothalamic peptide, antidepressin.
  • Antidepressin is identified as the active principle responsible for alleviating both neuroendocrine and behavioral abnormalities associated with affective disorders.

Conclusions:

  • The neuroendocrine hypothesis offers a plausible explanation for the therapeutic effects of convulsive therapy in affective disorders.
  • Targeting hypothalamic peptide systems, such as antidepressin, may represent a novel therapeutic strategy for mood disorders.

Related Experiment Videos